Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 496
interventional 398
Observational 90
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 172
Biological 37
Biological|Drug 25
Procedure 19
Drug|Procedure 16
Device 14
Biological|Drug|Procedure 11
Other 11
Drug|Other 10
Drug|placebo 10
Radiation 9
Behavioral 8
Biological|Drug|Other 5
Biological|Procedure 5
Biological|Drug|Procedure|Radiation 4
Behavioral|Drug 3
Biological|Other 3
Biological|Other|Procedure 3
Drug|Other|Procedure 3
Drug|Radiation 3
Procedure|Radiation 3
Biological|Drug|Other|Procedure|Radiation 2
Biological|Radiation 2
Device|Drug|Procedure 2
Device|Other 2
Other|Procedure 2
Behavioral|Drug|Procedure 1
Behavioral|Other|Procedure 1
Biological|Dietary Supplement 1
Biological|placebo 1
Combination Product 1
Combination Product|Drug 1
Device|Radiation 1
Diagnostic Test 1
Diagnostic Test|Drug 1
Dietary Supplement|Drug|placebo 1
Drug|Other|Radiation 1
Drug|placebo|Procedure 1
Genetic 1
Other|Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 248
France 22
Canada 11
United Kingdom 10
China 9
NA 9
United States|Canada 6
Denmark 5
Italy 5
Netherlands 5
Australia 4
Korea, Republic of 3
Germany 2
Israel 2
Japan 2
Russian Federation 2
Spain 2
Sweden 2
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 2
United States|Australia|Peru|Puerto Rico 2
United States|France 2
United States|France|Germany 2
United States|Puerto Rico 2
United States|Puerto Rico|South Africa 2
Austria|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Portugal|Slovakia|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|Germany|Hungary|Israel|Italy|Netherlands|Poland|Spain|United Kingdom 1
Austria|Belgium|Hungary|Israel|Italy|Netherlands|Turkey|United Kingdom 1
Belgium|France|Germany|Italy|Poland|Spain 1
Belgium|France|Israel|Italy|Netherlands|Spain|Switzerland 1
Belgium|Germany|Netherlands|Slovakia 1
Belgium|Hungary|Italy|Netherlands|Norway|Russian Federation|Switzerland|Turkey|United Kingdom 1
Brazil 1
Brazil|Canada|Finland|Netherlands|New Zealand|Norway|South Africa|United Kingdom 1
Finland 1
Germany|Netherlands 1
India 1
Poland 1
Switzerland 1
United States|Argentina|Australia|Canada|Czech Republic|Former Serbia and Montenegro|Germany|Greece|Hungary|Italy|Latvia|Lithuania|Mexico|Netherlands|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom| 1
United States|Argentina|Brazil|Canada 1
United States|Australia|Austria|Brazil|Canada|China|France|Germany|Greece|India|Ireland|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Canada|France|Greece|Indonesia|Italy|Korea, Republic of|Philippines|Singapore|Spain|Sweden|Switzerland|Thailand 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Taiwan|United Kingdom 1
United States|Australia|Canada|France|Netherlands|United Kingdom 1
United States|Australia|Canada|Israel 1
United States|Australia|Canada|Israel|New Zealand|Puerto Rico 1
United States|Australia|Canada|New Zealand|Puerto Rico 1
United States|Australia|China|Colombia|Czechia|Denmark|France|Germany|Greece|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Poland|Slovakia|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|France|Poland|United Kingdom 1
United States|Austria|Canada|Germany|Hong Kong|Italy|Japan|Switzerland|Taiwan 1
United States|Belgium|Canada|Germany|Netherlands|Spain|Sweden|United Kingdom 1
United States|Brazil|France|Italy|Korea, Republic of|Russian Federation|Ukraine 1
United States|Canada|France|Italy|Poland 1
United States|China|Bosnia and Herzegovina|Bulgaria|Chile|India|Malaysia|Mexico|Philippines|Romania|Russian Federation|South Africa|Taiwan|Ukraine 1
United States|France|Australia|Austria|Belgium|Canada|Denmark|Germany|Hungary|Israel|Italy|Netherlands|Poland|Slovakia|Spain|United Kingdom 1
United States|France|Germany|Hong Kong|Hungary|Italy|Netherlands|Spain|United Kingdom 1
United States|France|Germany|Israel|Poland|Romania|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Germany|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
United States|Netherlands 1
United States|Norway|United Kingdom 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 233
2 35
3 12
4 10
5 7
6 2
7 6
8 7
9 4
10 5
11 3
12 5
13 3
14 6
15 3
16 3
17 4
18 1
19 1
21 1
22 1
24 2
25 2
26 1
27 2
29 2
32 1
35 1
39 2
44 1
45 1
50 2
55 1
56 1
57 1
62 1
75 1
76 1
95 1
99 1
101 1
105 1
115 1
121 1
125 1
128 1
134 1
152 1
154 1
169 1
177 1
187 1
234 1
235 2
294 1
488 1
493 1
815 1
1003 1
1329 1

Phase

Phase Study_Count
Phase 2 174
Phase 1 77
N/A 59
Phase 3 36
Phase 1/Phase 2 33
Early Phase 1 9
Phase 4 8
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 152
2 94
3 20
4 11
5 2
6 5
8 2
9 1
12 1
14 1
17 1
37 1
NA 107

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 15.00000 1.0000 10.00000 4.000 2.0000 200.0 60.0000 20.00000
1st Qu. 25.00000 17.0000 17.25000 30.000 25.0000 209.5 224.5000 45.00000
Median 30.00000 56.0000 29.50000 49.000 41.0000 219.0 428.0000 50.00000
Mean 39.66667 764.1754 61.35714 67.875 104.9463 219.0 579.7812 59.14286
3rd Qu. 48.00000 180.0000 42.75000 74.250 63.0000 228.5 705.7500 78.50000
Max. 105.00000 35000.0000 770.00000 350.000 6452.0000 238.0 3031.0000 97.00000

Trial Group Type

group_type Group_Count
Experimental 474
NA 107
Active Comparator 57
No Intervention 22
Other 17
Placebo Comparator 17
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 188
Parallel Assignment 109
NA 87
Sequential Assignment 10
Crossover Assignment 2
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 340
Diagnostic 25
Supportive Care 13
Prevention 5
Basic Science 4
Other 4
Health Services Research 3
NA 3
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 31
France 13
NA 13
United Kingdom 6
Denmark 3
Canada 2
China 2
Germany 2
Japan 2
Switzerland 2
Australia 1
Austria|Belgium|France|Germany|Greece|Italy|Netherlands|Poland|Romania 1
Brazil 1
Croatia 1
Czechia|Poland 1
Israel 1
Italy 1
Korea, Republic of 1
Mexico 1
Netherlands 1
Slovakia 1
Turkey 1
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 67
2 5
3 4
4 3
5 1
6 1
7 2
14 2
15 1
21 1
66 1
118 1
232 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 50.00
Median 165.00
Mean 27579.55
3rd Qu 500.00
Max 2323608.00

Observation Model

observational_model Study_Count
Cohort 46
Case-Only 18
Case-Control 7
NA 7
Case Control 5
Other 4
Family-Based 2
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 53
Retrospective 26
NA 5
Cross-Sectional 4
Cross-Sectional, Prospective 1
Other 1

Registries

Studies by Country

Country Study_Count
United States 4
Denmark 2
Austria 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 6
6 2

Enrollment Metrics

Measure Registries
Min 60.00
1st Qu 448.50
Median 1050.00
Mean 1469.25
3rd Qu 1850.00
Max 5000.00

Registry Model

observational_model Study_Count
Cohort 5
Other 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 5
Other 3

Follow-up

target_duration Study_Count
5 Years 4
1 Year 1
24 Months 1
30 Years 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04416568 Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers https://ClinicalTrials.gov/show/NCT04416568 Recruiting Dana-Farber Cancer Institute 2023-10-31
NCT03977571 Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial https://ClinicalTrials.gov/show/NCT03977571 Recruiting University of Aarhus 2025-09-01
NCT01714765 Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer https://ClinicalTrials.gov/show/NCT01714765 Completed Queen Mary University of London 2012-10-31
NCT03824808 Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery https://ClinicalTrials.gov/show/NCT03824808 Recruiting University of Missouri-Columbia 2020-02-01
NCT03819569 GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses https://ClinicalTrials.gov/show/NCT03819569 Recruiting UNC Lineberger Comprehensive Cancer Center 2021-12-30
NCT03357289 Mix Vaccine for Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT03357289 Completed Fuda Cancer Hospital, Guangzhou 2018-11-30
NCT03354390 HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03354390 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT03334344 Using Virtual Reality (VR) Models for Preoperative Planning https://ClinicalTrials.gov/show/NCT03334344 Completed Ceevra, Inc. 2019-02-28
NCT03323021 Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy https://ClinicalTrials.gov/show/NCT03323021 Completed MiMedx Group, Inc. 2019-02-21
NCT03289962 A Study of RO7198457 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors https://ClinicalTrials.gov/show/NCT03289962 Recruiting Genentech, Inc. 2020-09-11
NCT03280667 Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma https://ClinicalTrials.gov/show/NCT03280667 Recruiting Australian and New Zealand Urogenital and Prostate Cancer Trials Group 2021-04-04
NCT03273751 The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy https://ClinicalTrials.gov/show/NCT03273751 Recruiting Seoul National University Hospital 2019-12-30
NCT03203473 Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) https://ClinicalTrials.gov/show/NCT03203473 Active, not recruiting Dana-Farber Cancer Institute 2020-11-30
NCT03185039 Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents https://ClinicalTrials.gov/show/NCT03185039 Recruiting Institut Paoli-Calmettes 2022-12-13
NCT03165721 A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer https://ClinicalTrials.gov/show/NCT03165721 Completed National Institutes of Health Clinical Center (CC) 2020-02-24
NCT03091192 Savolitinib vs. Sunitinib in MET-driven PRCC https://ClinicalTrials.gov/show/NCT03091192 Active, not recruiting AstraZeneca 2019-08-18
NCT03086174 Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma https://ClinicalTrials.gov/show/NCT03086174 Active, not recruiting Shanghai Junshi Bioscience Co., Ltd. 2019-12-31
NCT03073395 Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer https://ClinicalTrials.gov/show/NCT03073395 Recruiting Five Eleven Pharma, Inc. 2020-10-20
NCT03066427 Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. https://ClinicalTrials.gov/show/NCT03066427 Recruiting Spanish Oncology Genito-Urinary Group 2020-12-31
NCT03065179 Trial of SBRT in Combination With Nivolumab/Ipilimumab in RCC / Kidney Cancer Patients https://ClinicalTrials.gov/show/NCT03065179 Recruiting University of Texas Southwestern Medical Center 2020-01-31
NCT03064308 The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery https://ClinicalTrials.gov/show/NCT03064308 Completed University of Nottingham 2018-07-26
NCT03062410 Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03062410 Recruiting Centre Hospitalier Universitaire de Besancon 2019-11-04
NCT03053466 APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors https://ClinicalTrials.gov/show/NCT03053466 Active, not recruiting Apollomics (Australia) Pty. Ltd. 2020-02-29
NCT03024437 Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03024437 Recruiting Indiana University 2020-01-31
NCT03015740 Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT03015740 Active, not recruiting M.D. Anderson Cancer Center 2023-04-23
NCT02994758 Development of Diagnostics and Treatment of Urological Cancers https://ClinicalTrials.gov/show/NCT02994758 Recruiting Helsinki University Central Hospital 2020-12-31
NCT02992912 Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours https://ClinicalTrials.gov/show/NCT02992912 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2020-10-31
NCT02988219 Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method https://ClinicalTrials.gov/show/NCT02988219 Completed Medical University of Warsaw 2014-12-31
NCT02966509 Engagement of Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT02966509 Completed Stanford University 2016-12-31
NCT02964078 Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT02964078 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2019-03-26
NCT02950766 A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02950766 Recruiting Dana-Farber Cancer Institute 2021-06-30
NCT02947165 Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. https://ClinicalTrials.gov/show/NCT02947165 Recruiting Novartis 2021-04-13
NCT02946671 Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients https://ClinicalTrials.gov/show/NCT02946671 Completed Osaka University 2020-03-31
NCT02928692 Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium https://ClinicalTrials.gov/show/NCT02928692 Recruiting RenJi Hospital 2021-12-31
NCT02924922 Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy https://ClinicalTrials.gov/show/NCT02924922 Completed Luzerner Kantonsspital 2018-12-31
NCT02897778 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02897778 Completed Syndax Pharmaceuticals 2017-03-31
NCT02890069 A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat https://ClinicalTrials.gov/show/NCT02890069 Recruiting Novartis 2021-05-28
NCT02875548 Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study https://ClinicalTrials.gov/show/NCT02875548 Recruiting Epizyme, Inc. 2023-12-31
NCT02862288 Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. https://ClinicalTrials.gov/show/NCT02862288 Completed Centre Hospitalier Universitaire de Besancon 2015-02-28
NCT02812420 Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery https://ClinicalTrials.gov/show/NCT02812420 Active, not recruiting M.D. Anderson Cancer Center 2020-03-31
NCT02811250 Stereotactic Radiotherapy for Renal Cancers https://ClinicalTrials.gov/show/NCT02811250 Active, not recruiting Hospices Civils de Lyon 2018-02-28
NCT02762006 Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02762006 Active, not recruiting Case Comprehensive Cancer Center 2020-11-06
NCT02734329 Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage https://ClinicalTrials.gov/show/NCT02734329 Recruiting RenJi Hospital 2020-09-30
NCT02713269 Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord https://ClinicalTrials.gov/show/NCT02713269 Recruiting M.D. Anderson Cancer Center 2022-07-01
NCT02689167 Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02689167 Recruiting Centre Hospitalier Universitaire de Besancon 2020-02-29
NCT02687139 Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02687139 Completed Johns Hopkins University 2019-04-30
NCT02685553 Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project https://ClinicalTrials.gov/show/NCT02685553 Completed Universita di Verona 2016-10-31
NCT02643303 A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers https://ClinicalTrials.gov/show/NCT02643303 Recruiting Ludwig Institute for Cancer Research 2022-08-31
NCT02613819 Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney https://ClinicalTrials.gov/show/NCT02613819 Active, not recruiting Trans-Tasman Radiation Oncology Group (TROG) 2020-03-02
NCT02601950 A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma https://ClinicalTrials.gov/show/NCT02601950 Recruiting Epizyme, Inc. 2023-05-31
NCT02597322 Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN) https://ClinicalTrials.gov/show/NCT02597322 Completed Assistance Publique - Hôpitaux de Paris 2015-11-30
NCT02019693 A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer https://ClinicalTrials.gov/show/NCT02019693 Recruiting National Institutes of Health Clinical Center (CC) 2021-06-30
NCT03408652 Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies https://ClinicalTrials.gov/show/NCT03408652 Active, not recruiting Centre Leon Berard 2021-06-30
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT02465060 Recruiting National Cancer Institute (NCI) 2022-06-30
NCT03175224 APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03175224 Recruiting Apollomics Inc. 2021-09-30
NCT02496208 Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors https://ClinicalTrials.gov/show/NCT02496208 Recruiting National Cancer Institute (NCI) 2020-09-30
NCT02495103 Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02495103 Completed National Institutes of Health Clinical Center (CC) 2020-02-06
NCT02465892 Pillars4Life Trial https://ClinicalTrials.gov/show/NCT02465892 Completed Duke University 2016-10-31
NCT02431676 Survivorship Promotion In Reducing IGF-1 Trial https://ClinicalTrials.gov/show/NCT02431676 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2018-12-31
NCT02412670 Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer https://ClinicalTrials.gov/show/NCT02412670 Active, not recruiting Eastern Cooperative Oncology Group 2020-02-29
NCT02348008 Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: https://ClinicalTrials.gov/show/NCT02348008 Active, not recruiting Big Ten Cancer Research Consortium 2020-06-30
NCT02335827 Irreversible Electroporation(IRE) For Unresectable Renal Tumors https://ClinicalTrials.gov/show/NCT02335827 Recruiting Fuda Cancer Hospital, Guangzhou 2020-05-20
NCT02306954 Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer https://ClinicalTrials.gov/show/NCT02306954 Recruiting Providence Health & Services 2022-01-31
NCT02295982 Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence) https://ClinicalTrials.gov/show/NCT02295982 Completed Zealand University Hospital 2016-05-31
NCT02293980 A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02293980 Active, not recruiting Peloton Therapeutics, Inc. 2021-11-30
NCT02292914 Prospective Analysis of Robot-Assisted Surgery https://ClinicalTrials.gov/show/NCT02292914 Recruiting Instituto do Cancer do Estado de São Paulo 2020-07-10
NCT02210117 Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02210117 Active, not recruiting M.D. Anderson Cancer Center 2020-05-21
NCT02145559 A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02145559 Completed University of Chicago 2016-11-15
NCT02141919 Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer https://ClinicalTrials.gov/show/NCT02141919 Active, not recruiting University of Texas Southwestern Medical Center 2021-11-30
NCT02141490 Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers https://ClinicalTrials.gov/show/NCT02141490 Completed National Institutes of Health Clinical Center (CC) 2018-11-20
NCT02136121 Prospective Investigation of Robotic Single-port System https://ClinicalTrials.gov/show/NCT02136121 Completed Intuitive Surgical 2013-10-31
NCT02118337 A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies https://ClinicalTrials.gov/show/NCT02118337 Completed MedImmune LLC 2020-03-17
NCT02111850 T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive https://ClinicalTrials.gov/show/NCT02111850 Active, not recruiting National Institutes of Health Clinical Center (CC) 2023-12-29
NCT02077933 Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors https://ClinicalTrials.gov/show/NCT02077933 Completed Novartis 2019-04-12
NCT02061605 First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy https://ClinicalTrials.gov/show/NCT02061605 Active, not recruiting Laser Tissue Welding, Inc. 2020-12-31
NCT02060370 Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) https://ClinicalTrials.gov/show/NCT02060370 Completed M.D. Anderson Cancer Center 2019-01-02
NCT02035358 Immunotherapy Study for Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT02035358 Active, not recruiting Lumos Pharma 2017-01-03
NCT02016391 Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours https://ClinicalTrials.gov/show/NCT02016391 Completed Uppsala University Hospital 2014-12-31
NCT01968447 Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex https://ClinicalTrials.gov/show/NCT01968447 Completed Leiden University Medical Center 2015-10-31
NCT01950923 Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT01950923 Completed Wake Forest University Health Sciences 2016-03-31
NCT01908166 Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions https://ClinicalTrials.gov/show/NCT01908166 Completed Stanford University 2016-11-01
NCT01896778 Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer https://ClinicalTrials.gov/show/NCT01896778 Completed Roswell Park Cancer Institute 2018-02-23
NCT01894607 Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy https://ClinicalTrials.gov/show/NCT01894607 Completed M.D. Anderson Cancer Center 2014-12-31
NCT01846520 Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers https://ClinicalTrials.gov/show/NCT01846520 Completed City of Hope Medical Center 2019-05-23
NCT01835158 Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT01835158 Active, not recruiting National Cancer Institute (NCI) 2016-04-18
NCT01833728 A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy https://ClinicalTrials.gov/show/NCT01833728 Completed Yonsei University 2014-01-31
NCT01775930 Carfilzomib in Refractory Renal Cell Carcinoma (RCC) https://ClinicalTrials.gov/show/NCT01775930 Completed M.D. Anderson Cancer Center 2019-01-18
NCT01751529 Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer https://ClinicalTrials.gov/show/NCT01751529 Completed UNC Lineberger Comprehensive Cancer Center 2015-11-30
NCT01732120 Off Clamp Randomization https://ClinicalTrials.gov/show/NCT01732120 Active, not recruiting Washington University School of Medicine 2017-05-31
NCT01720706 Thermal Ablation in Larger Liver and Kidney Tumours https://ClinicalTrials.gov/show/NCT01720706 Completed University Health Network, Toronto 2017-08-31
NCT01715935 Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus https://ClinicalTrials.gov/show/NCT01715935 Completed Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 2015-06-30
NCT01688999 Cabozantinib for Advanced Urothelial Cancer https://ClinicalTrials.gov/show/NCT01688999 Active, not recruiting National Institutes of Health Clinical Center (CC) 2017-12-11
NCT01676428 A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases https://ClinicalTrials.gov/show/NCT01676428 Completed Peter MacCallum Cancer Centre, Australia 2014-10-31
NCT01608165 A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) https://ClinicalTrials.gov/show/NCT01608165 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2014-10-31
NCT01606787 Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes https://ClinicalTrials.gov/show/NCT01606787 Completed Memorial Sloan Kettering Cancer Center 2018-02-28
NCT01582204 Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01582204 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-04-30
NCT01571401 Trying Activity in Kidney Cancer Survivors (TRACKS) Trial https://ClinicalTrials.gov/show/NCT01571401 Completed University of Alberta 2012-11-30
NCT01497821 AMG 172 First in Human Study in Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT01497821 Completed Amgen 2014-11-30
NCT01497444 Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01497444 Completed Alliance for Clinical Trials in Oncology 2016-01-31
NCT01471002 Study to Evaluate the Efficacy of Percutaneous Cryoablation for Renal Tumours < 4cm in Patients Who Are Not Candidates for Partial Nephrectomy https://ClinicalTrials.gov/show/NCT01471002 Completed University Hospital, Strasbourg, France 2015-12-31
NCT01408004 Rotating Pazopanib and Everolimus to Avoid Resistance https://ClinicalTrials.gov/show/NCT01408004 Completed Netherlands Working Group on Immunotherapy of Oncology 2014-04-30
NCT01392183 Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) https://ClinicalTrials.gov/show/NCT01392183 Completed M.D. Anderson Cancer Center 2019-09-08
NCT00600496 A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) https://ClinicalTrials.gov/show/NCT00600496 Active, not recruiting AstraZeneca 2010-08-20
NCT04393350 Lenvatinib and Pembrolizumab Before Surgery for the Treatment of Locally Advanced Non-Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT04393350 Recruiting Emory University 2024-05-15
NCT04337970 Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT04337970 Recruiting Memorial Sloan Kettering Cancer Center 2022-10-31
NCT04322955 CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition https://ClinicalTrials.gov/show/NCT04322955 Recruiting Columbia University 2026-05-31
NCT04258462 Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Localized Renal Tumor https://ClinicalTrials.gov/show/NCT04258462 Recruiting University of California, San Francisco 2025-12-31
NCT04180774 Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer https://ClinicalTrials.gov/show/NCT04180774 Completed N.N. Petrov National Medical Research Center of Oncology 2018-12-31
NCT04162834 Effect of Papaverine on Renal Artery Blood Flow Volume https://ClinicalTrials.gov/show/NCT04162834 Recruiting Asan Medical Center 2020-10-31
NCT04157985 Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04157985 Recruiting University of Pittsburgh 2021-10-31
NCT04150562 Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma https://ClinicalTrials.gov/show/NCT04150562 Recruiting National Institutes of Health Clinical Center (CC) 2022-08-31
NCT04147494 Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues https://ClinicalTrials.gov/show/NCT04147494 Recruiting Jonsson Comprehensive Cancer Center 2030-06-01
NCT04134390 Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study https://ClinicalTrials.gov/show/NCT04134390 Recruiting Spanish Oncology Genito-Urinary Group 2022-12-31
NCT04127318 Low-moderate Intensity Pedaling During Immunotherapy Administration https://ClinicalTrials.gov/show/NCT04127318 Enrolling by invitation Rush University Medical Center 2020-10-31
NCT04115254 Stereotactic Magnetic Resonance Guided Radiation Therapy https://ClinicalTrials.gov/show/NCT04115254 Recruiting Dana-Farber Cancer Institute 2024-06-30
NCT04090710 SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT04090710 Recruiting Ontario Clinical Oncology Group (OCOG) 2021-12-31
NCT04021238 Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging https://ClinicalTrials.gov/show/NCT04021238 Recruiting UNC Lineberger Comprehensive Cancer Center 2022-05-31
NCT03934827 MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour https://ClinicalTrials.gov/show/NCT03934827 Recruiting Imperial College London 2021-08-31
NCT03907657 Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau https://ClinicalTrials.gov/show/NCT03907657 Recruiting UNC Lineberger Comprehensive Cancer Center 2021-07-31
NCT03887091 Personal Web Page In Clinical Trial Participant Education https://ClinicalTrials.gov/show/NCT03887091 Completed Dana-Farber Cancer Institute 2017-05-30
NCT03852030 Mind-Body Health in Uro-Oncology: Research Study https://ClinicalTrials.gov/show/NCT03852030 Completed Northwestern University 2016-07-31
NCT03849820 Open vs Robotic Assisted Partial Nephrectomy https://ClinicalTrials.gov/show/NCT03849820 Recruiting Intuitive Surgical 2021-02-28
NCT03810651 Pencil Beam Scanning in Patients With Renal Tumors https://ClinicalTrials.gov/show/NCT03810651 Recruiting Children’s Hospital of Philadelphia 2022-06-30
NCT03804320 Protocol Active Surveillance Small Renal Masses (SRMs) https://ClinicalTrials.gov/show/NCT03804320 Recruiting IRCCS San Raffaele 2023-12-11
NCT03787056 Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients https://ClinicalTrials.gov/show/NCT03787056 Recruiting Hospices Civils de Lyon 2026-11-30
NCT03786796 Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations https://ClinicalTrials.gov/show/NCT03786796 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2021-03-31
NCT03747133 SABR for Renal Tumors https://ClinicalTrials.gov/show/NCT03747133 Recruiting University Health Network, Toronto 2020-11-30
NCT03736330 A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma https://ClinicalTrials.gov/show/NCT03736330 Recruiting Sun Yat-sen University 2020-10-08
NCT03715985 Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac) https://ClinicalTrials.gov/show/NCT03715985 Recruiting Herlev Hospital 2021-01-01
NCT03693014 A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors https://ClinicalTrials.gov/show/NCT03693014 Recruiting Memorial Sloan Kettering Cancer Center 2021-10-31
NCT03679572 Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared Fluorescence https://ClinicalTrials.gov/show/NCT03679572 Active, not recruiting University Hospital, Grenoble 2020-02-10
NCT03678883 9-ING-41 in Patients With Advanced Cancers https://ClinicalTrials.gov/show/NCT03678883 Recruiting Actuate Therapeutics Inc. 2022-11-30
NCT03666104 Using Virtual Reality (VR) Models for Preoperative Planning - Mount Sinai https://ClinicalTrials.gov/show/NCT03666104 Completed Ceevra, Inc. 2019-02-28
NCT03652298 Effects of a Neuroscience-based Technique on Post-traumatic Stress Disorder Symptoms, Inflammation, and Survival in Cancer Patients Announced of a Palliative Disease Progression and Their Partners https://ClinicalTrials.gov/show/NCT03652298 Recruiting Centre Oscar Lambret 2020-05-25
NCT03638206 Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies https://ClinicalTrials.gov/show/NCT03638206 Recruiting Shenzhen BinDeBio Ltd. 2023-03-01
NCT03634540 A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) https://ClinicalTrials.gov/show/NCT03634540 Recruiting Peloton Therapeutics, Inc. 2023-08-14
NCT03623490 Optimizing the Management of Patients With Oral Therapy https://ClinicalTrials.gov/show/NCT03623490 Recruiting Centre Georges Francois Leclerc 2018-05-22
NCT03617913 Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer https://ClinicalTrials.gov/show/NCT03617913 Active, not recruiting Mayo Clinic 2019-11-14
NCT03571438 Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors https://ClinicalTrials.gov/show/NCT03571438 Recruiting University Hospital, Grenoble 2022-09-30
NCT03556943 Using Virtual Reality (VR) Models for Preoperative Planning - Mayo Clinic https://ClinicalTrials.gov/show/NCT03556943 Completed Ceevra, Inc. 2019-02-28
NCT03556046 89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE https://ClinicalTrials.gov/show/NCT03556046 Completed Radboud University 2018-12-17
NCT03534206 Using Virtual Reality (VR) Models for Preoperative Planning - University of Tennessee https://ClinicalTrials.gov/show/NCT03534206 Completed Ceevra, Inc. 2019-02-28
NCT03522155 Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies https://ClinicalTrials.gov/show/NCT03522155 Recruiting Cedars-Sinai Medical Center 2022-09-30
NCT03520231 Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases https://ClinicalTrials.gov/show/NCT03520231 Recruiting University Health Network, Toronto 2019-12-01
NCT03514550 Effects of Anesthesia on Immunity in Cancer https://ClinicalTrials.gov/show/NCT03514550 Completed Meshalkin Research Institute of Pathology of Circulation 2019-04-01
NCT03513952 Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT03513952 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT03473730 Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT03473730 Recruiting M.D. Anderson Cancer Center 2021-12-31
NCT03470285 Multiparametric MRI for Diagnosing Small Renal Tumors https://ClinicalTrials.gov/show/NCT03470285 Recruiting University Hospital, Bordeaux 2021-07-31
NCT03469713 Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03469713 Recruiting Gruppo Oncologico Italiano di Ricerca Clinica 2019-07-14
NCT03444766 Study of Nivolumab for Advanced Cancers in India https://ClinicalTrials.gov/show/NCT03444766 Completed Bristol-Myers Squibb 2019-07-17
NCT03421418 Using Virtual Reality (VR) Models for Preoperative Planning - UNC https://ClinicalTrials.gov/show/NCT03421418 Completed Ceevra, Inc. 2019-02-28
NCT01263769 Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) https://ClinicalTrials.gov/show/NCT01263769 Active, not recruiting M.D. Anderson Cancer Center 2020-02-29
NCT01218854 A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy https://ClinicalTrials.gov/show/NCT01218854 Completed National Institutes of Health Clinical Center (CC) 2016-11-16
NCT01217931 Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial https://ClinicalTrials.gov/show/NCT01217931 Active, not recruiting M.D. Anderson Cancer Center 2020-01-31
NCT01191892 Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer https://ClinicalTrials.gov/show/NCT01191892 Completed Cardiff University 2015-12-31
NCT01184326 Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer https://ClinicalTrials.gov/show/NCT01184326 Completed Dana-Farber Cancer Institute 2017-03-31
NCT01164228 Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01164228 Active, not recruiting Eastern Cooperative Oncology Group 2018-05-31
NCT01154816 Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia https://ClinicalTrials.gov/show/NCT01154816 Completed Children’s Oncology Group 2015-12-31
NCT01122615 Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) https://ClinicalTrials.gov/show/NCT01122615 Completed M.D. Anderson Cancer Center 2014-07-31
NCT01120249 S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery https://ClinicalTrials.gov/show/NCT01120249 Active, not recruiting Southwest Oncology Group 2021-10-31
NCT01090466 Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT01090466 Completed Cardiff University 2010-01-31
NCT01089088 Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) https://ClinicalTrials.gov/show/NCT01089088 Completed Cardiff University 2014-10-31
NCT01038778 Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT01038778 Active, not recruiting National Cancer Institute (NCI) 2019-05-22
NCT01034878 Sunitinib in Metastatic Renal Cancer https://ClinicalTrials.gov/show/NCT01034878 Completed Istituto Clinico Humanitas 2014-12-31
NCT01031875 Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment https://ClinicalTrials.gov/show/NCT01031875 Completed National Cancer Institute (NCI) 2011-12-31
NCT01024205 Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT01024205 Completed National Cancer Institute (NCI) 2010-08-31
NCT01005797 Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers https://ClinicalTrials.gov/show/NCT01005797 Completed Medical University of South Carolina 2014-03-31
NCT00979966 Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib https://ClinicalTrials.gov/show/NCT00979966 Completed Central European Society for Anticancer Drug Research 2012-07-31
NCT00967577 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00967577 Active, not recruiting Weill Medical College of Cornell University 2018-06-30
NCT00945009 Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT00945009 Active, not recruiting Children’s Oncology Group 2016-12-31
NCT00943839 Sunitinib Malate in Treating Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT00943839 Completed Centre Antoine Lacassagne 2014-11-30
NCT00920816 Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00920816 Active, not recruiting Pfizer 2012-07-27
NCT00896454 Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium https://ClinicalTrials.gov/show/NCT00896454 Completed Amgen 2012-09-13
NCT00888641 A Pilot Study of Renal Hypothermia During Partial Nephrectomy https://ClinicalTrials.gov/show/NCT00888641 Completed Mayo Clinic 2011-05-31
NCT00866320 Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab https://ClinicalTrials.gov/show/NCT00866320 Completed Case Comprehensive Cancer Center 2009-12-31
NCT00854620 Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT00854620 Completed Stanford University 2009-07-31
NCT00853021 Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney https://ClinicalTrials.gov/show/NCT00853021 Completed Case Comprehensive Cancer Center 2009-10-31
NCT00849186 Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00849186 Completed Roswell Park Cancer Institute 2009-07-31
NCT03542565 Using Virtual Reality (VR) Models for Preoperative Planning - JWCI https://ClinicalTrials.gov/show/NCT03542565 Completed Ceevra, Inc. 2019-02-28
NCT03540199 Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT03540199 Recruiting Fuda Cancer Hospital, Guangzhou 2020-05-20
NCT02724878 Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02724878 Active, not recruiting Dana-Farber Cancer Institute 2019-11-13
NCT00827359 Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00827359 Completed Dana-Farber Cancer Institute 2018-01-31
NCT04120805 Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy https://ClinicalTrials.gov/show/NCT04120805 Recruiting University of Chicago 2022-03-01
NCT02849535 Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT02849535 Recruiting Hospices Civils de Lyon 2021-04-30
NCT03983954 Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT03983954 Recruiting NeoTX Therapeutics Ltd. 2021-11-01
NCT00814021 Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain https://ClinicalTrials.gov/show/NCT00814021 Completed Institut Claudius Regaud 2010-12-31
NCT00807339 CyberKnife for Unresectable Renal Tumors https://ClinicalTrials.gov/show/NCT00807339 Completed Beth Israel Deaconess Medical Center 2014-01-01
NCT03308396 Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT03308396 Recruiting Big Ten Cancer Research Consortium 2019-12-01
NCT03244384 Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer https://ClinicalTrials.gov/show/NCT03244384 Recruiting National Cancer Institute (NCI) 2025-06-01
NCT02437370 Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer https://ClinicalTrials.gov/show/NCT02437370 Recruiting University of California, Davis 2020-06-30
NCT03755739 Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors for Immunotherapy of Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03755739 Recruiting Second Affiliated Hospital of Guangzhou Medical University 2033-11-01
NCT01012427 Percutaneous Renal Tumor Cryoablation Followed by Biopsy https://ClinicalTrials.gov/show/NCT01012427 Completed Memorial Sloan Kettering Cancer Center 2015-09-30
NCT00792025 Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer https://ClinicalTrials.gov/show/NCT00792025 Completed National Cancer Institute (NCI) 2011-05-31
NCT00782275 Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00782275 Completed Dana-Farber Cancer Institute 2015-05-31
NCT00749892 Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer https://ClinicalTrials.gov/show/NCT00749892 Completed M.D. Anderson Cancer Center 2019-06-30
NCT00743236 Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer https://ClinicalTrials.gov/show/NCT00743236 Completed Wake Forest University Health Sciences 2009-06-30
NCT00729053 Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma https://ClinicalTrials.gov/show/NCT00729053 Completed Idera Pharmaceuticals, Inc. 2008-04-30
NCT00722228 Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors https://ClinicalTrials.gov/show/NCT00722228 Recruiting Hadassah Medical Organization 2021-01-31
NCT00688753 RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe https://ClinicalTrials.gov/show/NCT00688753 Completed Novartis 2014-10-31
NCT00678392 Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00678392 Completed Pfizer 2010-08-31
NCT00671411 Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast https://ClinicalTrials.gov/show/NCT00671411 Completed Memorial Sloan Kettering Cancer Center 2011-11-30
NCT00659568 Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma https://ClinicalTrials.gov/show/NCT00659568 Completed National Cancer Institute (NCI) 2010-02-28
NCT00656734 Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. https://ClinicalTrials.gov/show/NCT00656734 Completed Bristol-Myers Squibb 2010-06-30
NCT00623064 Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer https://ClinicalTrials.gov/show/NCT00623064 Completed European Organisation for Research and Treatment of Cancer - EORTC 2012-06-30
NCT00622674 Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00622674 Completed Masonic Cancer Center, University of Minnesota 2009-08-31
NCT00620295 Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00620295 Completed Masonic Cancer Center, University of Minnesota 2009-02-28
NCT00606632 Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody https://ClinicalTrials.gov/show/NCT00606632 Completed Wilex 2009-11-30
NCT00588913 Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases https://ClinicalTrials.gov/show/NCT00588913 Completed National Cancer Institute (NCI) 2009-03-31
NCT00588276 Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors https://ClinicalTrials.gov/show/NCT00588276 Completed Memorial Sloan Kettering Cancer Center 2012-06-30
NCT00581815 Spectroscopy With Surface Coils and Decoupling https://ClinicalTrials.gov/show/NCT00581815 Completed Memorial Sloan Kettering Cancer Center 2014-02-28
NCT00579514 Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients https://ClinicalTrials.gov/show/NCT00579514 Recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT00566995 Phase II Study of Vandetanib in Individuals With Kidney Cancer https://ClinicalTrials.gov/show/NCT00566995 Completed National Institutes of Health Clinical Center (CC) 2014-06-20
NCT00550277 LBH589 Treatment for Refractory Clear Cell Renal Carcinoma https://ClinicalTrials.gov/show/NCT00550277 Completed SCRI Development Innovations, LLC 2010-03-31
NCT00537056 Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI https://ClinicalTrials.gov/show/NCT00537056 Completed Stanford University 2011-10-31
NCT00531284 Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma https://ClinicalTrials.gov/show/NCT00531284 Completed Amgen 2014-10-31
NCT00514215 Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer https://ClinicalTrials.gov/show/NCT00514215 Completed Barbara Ann Karmanos Cancer Institute 2010-03-31
NCT00505310 Biobehavioral Effects of Emotional Expression in Cancer https://ClinicalTrials.gov/show/NCT00505310 Active, not recruiting M.D. Anderson Cancer Center 2021-08-31
NCT00498966 Ph II Study of Perifosine for Patients With Carcinoma of the Kidney https://ClinicalTrials.gov/show/NCT00498966 Completed AEterna Zentaris 2011-07-31
NCT00496587 Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00496587 Completed M.D. Anderson Cancer Center 2016-05-31
NCT00492258 Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer https://ClinicalTrials.gov/show/NCT00492258 Completed National Cancer Institute (NCI) 2012-08-31
NCT00490698 Zoledronate With Atorvastatin in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00490698 Completed M.D. Anderson Cancer Center 2012-01-31
NCT00478361 Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function https://ClinicalTrials.gov/show/NCT00478361 Completed M.D. Anderson Cancer Center 2015-06-30
NCT00471432 OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors https://ClinicalTrials.gov/show/NCT00471432 Completed Canadian Cancer Trials Group 2006-03-09
NCT00465179 Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00465179 Completed M.D. Anderson Cancer Center 2015-03-31
NCT00462982 Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma https://ClinicalTrials.gov/show/NCT00462982 Completed Memorial Sloan Kettering Cancer Center 2008-08-31
NCT00459979 Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00459979 Completed Case Comprehensive Cancer Center 2011-03-31
NCT00459875 Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00459875 Completed Memorial Sloan Kettering Cancer Center 2010-11-30
NCT00458536 Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF https://ClinicalTrials.gov/show/NCT00458536 Active, not recruiting Dana-Farber Cancer Institute 2014-12-31
NCT00458484 Radiosurgery in Treating Patients With Kidney Tumors https://ClinicalTrials.gov/show/NCT00458484 Active, not recruiting Case Comprehensive Cancer Center 2019-08-26
NCT00455975 High-dose Bevacizumab in Advanced Renal Carcinoma Patients https://ClinicalTrials.gov/show/NCT00455975 Completed SCRI Development Innovations, LLC 2013-07-31
NCT00019630 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00019630 Completed National Cancer Institute (NCI) NA
NCT00441337 A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies https://ClinicalTrials.gov/show/NCT00441337 Completed Bristol-Myers Squibb 2009-11-30
NCT00425386 Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00425386 Completed OHSU Knight Cancer Institute 2010-08-31
NCT00422344 A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00422344 Completed Memorial Sloan Kettering Cancer Center 2010-02-28
NCT00421512 A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients https://ClinicalTrials.gov/show/NCT00421512 Completed Memorial Sloan Kettering Cancer Center 2008-05-31
NCT00418496 Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00418496 Completed Ohio State University Comprehensive Cancer Center 2013-02-28
NCT00416871 Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00416871 Completed Centre Leon Berard NA
NCT00416429 Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00416429 Completed Centre Leon Berard NA
NCT00407485 VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00407485 Completed National Cancer Institute (NCI) 2010-04-30
NCT00405366 Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer https://ClinicalTrials.gov/show/NCT00405366 Completed UNC Lineberger Comprehensive Cancer Center 2009-06-30
NCT00403169 Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer https://ClinicalTrials.gov/show/NCT00403169 Completed The Cleveland Clinic 2009-05-31
NCT00401128 Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00401128 Completed The Cleveland Clinic 2007-02-28
NCT00399152 Perifosine + Sunitinib Malate for Patients With Advanced Cancers https://ClinicalTrials.gov/show/NCT00399152 Completed AEterna Zentaris 2008-12-31
NCT00398814 Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers https://ClinicalTrials.gov/show/NCT00398814 Completed AEterna Zentaris 2011-09-30
NCT00397488 Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00397488 Completed Memorial Sloan Kettering Cancer Center 2012-02-29
NCT00397345 TroVax Renal Immunotherapy Survival Trial https://ClinicalTrials.gov/show/NCT00397345 Completed Oxford BioMedica 2009-12-31
NCT00392821 Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00392821 Completed SCRI Development Innovations, LLC 2013-10-31
NCT00381173 A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing https://ClinicalTrials.gov/show/NCT00381173 Completed Eisai Inc. 2008-10-31
NCT00375674 A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00375674 Completed Pfizer 2016-04-07
NCT00369564 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00369564 Completed University of South Florida 2012-11-30
NCT00365768 Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors https://ClinicalTrials.gov/show/NCT00365768 Completed Columbia University 2012-06-30
NCT00365287 Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer https://ClinicalTrials.gov/show/NCT00365287 Completed Masonic Cancer Center, University of Minnesota 2005-12-31
NCT00335556 Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors https://ClinicalTrials.gov/show/NCT00335556 Completed Children’s Oncology Group 2015-12-31
NCT00331409 Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer https://ClinicalTrials.gov/show/NCT00331409 Completed OHSU Knight Cancer Institute 2010-01-31
NCT00323739 Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma https://ClinicalTrials.gov/show/NCT00323739 Completed SCRI Development Innovations, LLC 2008-11-30
NCT00316901 Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial https://ClinicalTrials.gov/show/NCT00316901 Completed National Institutes of Health Clinical Center (CC) 2007-12-31
NCT00310011 Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00310011 Completed Wake Forest University Health Sciences 2005-10-31
NCT00303732 Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00303732 Completed Duke University 2010-08-31
NCT00301847 Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain https://ClinicalTrials.gov/show/NCT00301847 Completed National Cancer Institute (NCI) 2007-06-30
NCT00282048 Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00282048 Completed Pfizer 2009-02-28
NCT00278369 Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer https://ClinicalTrials.gov/show/NCT00278369 Completed Northwestern University 2009-06-30
NCT00278174 Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00278174 Completed Case Comprehensive Cancer Center 2007-04-30
NCT00276835 Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer https://ClinicalTrials.gov/show/NCT00276835 Completed Northwestern University 2007-07-31
NCT00276614 Bortezomib in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00276614 Completed Jonsson Comprehensive Cancer Center 2009-07-31
NCT00276536 Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma https://ClinicalTrials.gov/show/NCT00276536 Completed The Cleveland Clinic 2004-01-31
NCT00262886 Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00262886 Completed University of Rochester 2007-07-31
NCT00241163 TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN) https://ClinicalTrials.gov/show/NCT00241163 Completed Takeda NA
NCT00226980 A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00226980 Completed Stanford University 2005-07-31
NCT00199888 Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. https://ClinicalTrials.gov/show/NCT00199888 Completed Ludwig Institute for Cancer Research NA
NCT00199875 Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 https://ClinicalTrials.gov/show/NCT00199875 Completed Ludwig Institute for Cancer Research 2013-03-14
NCT00193154 OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00193154 Completed SCRI Development Innovations, LLC 2004-01-31
NCT00142415 Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer https://ClinicalTrials.gov/show/NCT00142415 Completed Ludwig Institute for Cancer Research 2011-01-31
NCT00134186 Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer https://ClinicalTrials.gov/show/NCT00134186 Completed Pharmacyclics LLC. NA
NCT00123773 Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence https://ClinicalTrials.gov/show/NCT00123773 Completed AHS Cancer Control Alberta 2008-12-31
NCT00118326 Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease https://ClinicalTrials.gov/show/NCT00118326 Completed Fred Hutchinson Cancer Research Center NA
NCT00113217 Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00113217 Completed M.D. Anderson Cancer Center 2012-08-31
NCT00112671 Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract https://ClinicalTrials.gov/show/NCT00112671 Completed National Cancer Institute (NCI) 2010-05-31
NCT00101608 Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium https://ClinicalTrials.gov/show/NCT00101608 Completed Bristol-Myers Squibb 2007-04-30
NCT00100906 Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00100906 Completed H. Lee Moffitt Cancer Center and Research Institute 2006-06-30
NCT00098943 NGR-TNF in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00098943 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-11-30
NCT00096629 Vaccine Therapy in Treating Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT00096629 Completed Memorial Sloan Kettering Cancer Center 2018-04-30
NCT00096525 Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer https://ClinicalTrials.gov/show/NCT00096525 Completed Memorial Sloan Kettering Cancer Center 2005-08-31
NCT00095108 Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00095108 Completed ZymoGenetics 2007-01-31
NCT00093405 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00093405 Completed National Cancer Institute (NCI) NA
NCT00003551 Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer https://ClinicalTrials.gov/show/NCT00003551 Completed National Cancer Institute (NCI) NA
NCT00003390 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00003390 Completed National Cancer Institute (NCI) NA
NCT00003102 Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00003102 Completed Ludwig Institute for Cancer Research 2000-08-31
NCT00002914 Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract https://ClinicalTrials.gov/show/NCT00002914 Completed Eastern Cooperative Oncology Group 2001-06-30
NCT00005056 Bryostatin 1 In Treating Patients With Progressive Kidney Cancer https://ClinicalTrials.gov/show/NCT00005056 Completed National Cancer Institute (NCI) NA
NCT00003542 Interferon Alfa in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00003542 Completed Memorial Sloan Kettering Cancer Center 2004-04-30
NCT00088374 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease https://ClinicalTrials.gov/show/NCT00088374 Completed National Institutes of Health Clinical Center (CC) 2009-01-31
NCT00003585 Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer https://ClinicalTrials.gov/show/NCT00003585 Completed University of New Mexico 2001-08-31
NCT00087022 Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00087022 Completed Wilex 2012-10-31
NCT00003091 High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma https://ClinicalTrials.gov/show/NCT00003091 Completed Hoag Memorial Hospital Presbyterian 2000-01-31
NCT00002733 Biological Therapy in Treating Patients With Metastatic Cancer https://ClinicalTrials.gov/show/NCT00002733 Completed Hoag Memorial Hospital Presbyterian 2000-01-31
NCT00085436 DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC https://ClinicalTrials.gov/show/NCT00085436 Completed Dartmouth-Hitchcock Medical Center 2009-10-31
NCT00005045 Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00005045 Completed National Cancer Institute (NCI) NA
NCT00003584 Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00003584 Completed University of New Mexico 2000-12-31
NCT00005069 Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00005069 Completed Memorial Sloan Kettering Cancer Center 2001-07-31
NCT00004880 Vaccine Therapy in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00004880 Completed Jonsson Comprehensive Cancer Center 2001-04-30
NCT00082914 Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00082914 Completed National Cancer Institute (NCI) NA
NCT00002737 Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00002737 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-01-31
NCT00003968 Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00003968 Completed National Cancer Institute (NCI) 2003-12-31
NCT00003175 Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer https://ClinicalTrials.gov/show/NCT00003175 Completed National Cancer Institute (NCI) NA
NCT00003133 Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer https://ClinicalTrials.gov/show/NCT00003133 Completed Memorial Sloan Kettering Cancer Center 2003-01-31
NCT00006483 Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung https://ClinicalTrials.gov/show/NCT00006483 Completed Alliance for Clinical Trials in Oncology 2003-01-31
NCT00003914 Dolastatin 10 in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00003914 Completed Mayo Clinic 2002-08-31
NCT00002764 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00002764 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-11-30
NCT00003376 Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00003376 Completed Eastern Cooperative Oncology Group 2005-09-30
NCT00080873 Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00080873 Completed Children’s Oncology Group 2006-11-30
NCT00080795 Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium https://ClinicalTrials.gov/show/NCT00080795 Completed M.D. Anderson Cancer Center 2006-05-31
NCT00003103 Chemotherapy in Treating Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00003103 Completed Memorial Sloan Kettering Cancer Center 2002-08-31
NCT00020540 Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00020540 Completed National Cancer Institute (NCI) NA
NCT00006376 R115777 in Treating Patients With Advanced Bladder Cancer https://ClinicalTrials.gov/show/NCT00006376 Completed National Cancer Institute (NCI) NA
NCT00005816 Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer https://ClinicalTrials.gov/show/NCT00005816 Completed Duke University NA
NCT00006026 Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract https://ClinicalTrials.gov/show/NCT00006026 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-10-31
NCT00004223 Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer https://ClinicalTrials.gov/show/NCT00004223 Completed Eastern Cooperative Oncology Group 2002-10-31
NCT00021021 RPI.4610 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00021021 Completed National Cancer Institute (NCI) NA
NCT00005995 AE-941 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00005995 Completed AEterna Zentaris 2007-03-31
NCT00004203 Oxaliplatin in Treating Patients With Metastatic Bladder Cancer https://ClinicalTrials.gov/show/NCT00004203 Completed University of Chicago 2002-02-28
NCT00077129 Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00077129 Completed Eastern Cooperative Oncology Group 2006-08-31
NCT00076011 Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00076011 Completed Pfizer 2007-02-28
NCT00075660 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00075660 Completed Canadian Cancer Trials Group 2005-10-04
NCT00016237 Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment https://ClinicalTrials.gov/show/NCT00016237 Completed EMD Serono NA
NCT00014183 ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer https://ClinicalTrials.gov/show/NCT00014183 Completed University of Maryland, Baltimore 2002-05-31
NCT00006384 SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00006384 Completed City of Hope Medical Center 2007-02-28
NCT00004890 Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT00004890 Completed National Cancer Institute (NCI) 2002-12-31
NCT00073879 Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00073879 Completed Baylor College of Medicine 2004-04-30
NCT00072150 Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma https://ClinicalTrials.gov/show/NCT00072150 Completed National Cancer Institute (NCI) 2006-03-31
NCT00072046 Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) https://ClinicalTrials.gov/show/NCT00072046 Completed Alliance for Clinical Trials in Oncology 2004-01-31
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00014144 S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract https://ClinicalTrials.gov/show/NCT00014144 Completed Southwest Oncology Group 2003-05-31
NCT00021099 Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer https://ClinicalTrials.gov/show/NCT00021099 Completed National Cancer Institute (NCI) 2007-08-31
NCT00069160 Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer https://ClinicalTrials.gov/show/NCT00069160 Completed National Institutes of Health Clinical Center (CC) 2009-12-31
NCT00016939 Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00016939 Completed National Cancer Institute (NCI) NA
NCT00011973 Chemotherapy in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00011973 Completed Barbara Ann Karmanos Cancer Institute 2005-10-31
NCT00005027 Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00005027 Completed Barbara Ann Karmanos Cancer Institute 2005-03-31
NCT00066612 S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy https://ClinicalTrials.gov/show/NCT00066612 Completed Southwest Oncology Group 2007-08-31
NCT00066352 Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter https://ClinicalTrials.gov/show/NCT00066352 Completed University Health Network, Toronto 2003-09-30
NCT00065468 Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00065468 Completed Pfizer 2006-06-30
NCT00006968 Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00006968 Completed Jonsson Comprehensive Cancer Center 2004-09-30
NCT00025376 PS-341 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00025376 Completed University of Chicago 2002-09-30
NCT00006864 Interleukin-2 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00006864 Completed Case Comprehensive Cancer Center 2007-07-31
NCT00059735 A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT00059735 Completed Eisai Inc. NA
NCT00004095 Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00004095 Completed Northwestern University 2008-10-31
NCT00018941 Interleukin-2 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00018941 Completed National Cancer Institute (NCI) NA
NCT00058318 S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer https://ClinicalTrials.gov/show/NCT00058318 Completed Southwest Oncology Group 2007-05-31
NCT00057889 Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer https://ClinicalTrials.gov/show/NCT00057889 Completed National Institutes of Health Clinical Center (CC) 2007-10-31
NCT00056537 ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer https://ClinicalTrials.gov/show/NCT00056537 Completed Active Biotech AB 2006-12-31
NCT00056095 Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00056095 Completed UNICANCER 2008-02-13
NCT00054886 Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00054886 Completed Pfizer NA
NCT00053820 Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00053820 Completed National Cancer Institute (NCI) NA
NCT00053807 Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer https://ClinicalTrials.gov/show/NCT00053807 Completed European Organisation for Research and Treatment of Cancer - EORTC 2004-01-31
NCT00053209 Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00053209 Completed Eastern Cooperative Oncology Group 2007-09-30
NCT00045630 S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00045630 Completed Southwest Oncology Group 2008-05-31
NCT00045487 Erlotinib in Treating Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00045487 Completed The University of Texas Health Science Center at San Antonio 2008-05-31
NCT00045370 Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00045370 Completed Memorial Sloan Kettering Cancer Center 2003-11-30
NCT00045279 PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00045279 Completed Memorial Sloan Kettering Cancer Center 2005-09-30
NCT00042965 Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00042965 Completed Alliance for Clinical Trials in Oncology 2006-09-30
NCT00041106 Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer https://ClinicalTrials.gov/show/NCT00041106 Completed National Cancer Institute (NCI) 2007-07-31
NCT00039429 Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00039429 Completed Eastern Cooperative Oncology Group 2006-04-30
NCT00039052 Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer https://ClinicalTrials.gov/show/NCT00039052 Completed National Cancer Institute (NCI) 2003-05-31
NCT00031564 Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 https://ClinicalTrials.gov/show/NCT00031564 Completed H. Lee Moffitt Cancer Center and Research Institute 2005-06-30
NCT00030342 Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00030342 Completed National Cancer Institute (NCI) 2007-10-31
NCT00028860 Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer https://ClinicalTrials.gov/show/NCT00028860 Completed National Cancer Institute (NCI) NA
NCT00027573 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer https://ClinicalTrials.gov/show/NCT00027573 Completed Alliance for Clinical Trials in Oncology 2006-06-30
NCT00022191 Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer https://ClinicalTrials.gov/show/NCT00022191 Completed European Organisation for Research and Treatment of Cancer - EORTC 2004-06-30
NCT00020527 Caspofungin Acetate in Treating Children With Fever and Neutropenia https://ClinicalTrials.gov/show/NCT00020527 Completed National Cancer Institute (NCI) NA
NCT00019955 Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) https://ClinicalTrials.gov/show/NCT00019955 Completed National Cancer Institute (NCI) NA
NCT00017329 PS-341 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00017329 Completed National Cancer Institute (NCI) 2004-04-30
NCT00014274 Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium https://ClinicalTrials.gov/show/NCT00014274 Completed European Organisation for Research and Treatment of Cancer - EORTC 2008-03-31
NCT00006351 SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract https://ClinicalTrials.gov/show/NCT00006351 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-12-31
NCT00006255 Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases https://ClinicalTrials.gov/show/NCT00006255 Completed Case Comprehensive Cancer Center 2005-03-31
NCT00006022 Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer https://ClinicalTrials.gov/show/NCT00006022 Completed Virginia Commonwealth University 2003-10-31
NCT00005966 Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer https://ClinicalTrials.gov/show/NCT00005966 Completed National Cancer Institute (NCI) 2006-03-31
NCT00005831 Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer https://ClinicalTrials.gov/show/NCT00005831 Completed National Cancer Institute (NCI) 2004-08-31
NCT00005644 Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function https://ClinicalTrials.gov/show/NCT00005644 Completed Eastern Cooperative Oncology Group 2003-02-28
NCT00004879 Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer https://ClinicalTrials.gov/show/NCT00004879 Completed Jonsson Comprehensive Cancer Center 2005-07-31
NCT00004244 Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma https://ClinicalTrials.gov/show/NCT00004244 Completed National Cancer Institute (NCI) 2005-07-31
NCT00004135 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00004135 Completed University of Chicago 2004-10-31
NCT00003928 Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00003928 Completed Case Comprehensive Cancer Center 2005-02-28
NCT00003656 Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00003656 Completed Weill Medical College of Cornell University 2008-05-31
NCT00003553 Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00003553 Completed National Institutes of Health Clinical Center (CC) 2011-06-27
NCT00003342 Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer https://ClinicalTrials.gov/show/NCT00003342 Completed Memorial Sloan Kettering Cancer Center 2007-07-31
NCT00003308 Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma https://ClinicalTrials.gov/show/NCT00003308 Completed Eastern Cooperative Oncology Group 2004-09-30
NCT00003105 Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer https://ClinicalTrials.gov/show/NCT00003105 Completed Memorial Sloan Kettering Cancer Center 2004-08-31
NCT00002641 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00002641 Completed European Organisation for Research and Treatment of Cancer - EORTC 2006-02-28
NCT00002611 Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer https://ClinicalTrials.gov/show/NCT00002611 Completed Children’s Oncology Group 2002-06-30
NCT00002610 Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors https://ClinicalTrials.gov/show/NCT00002610 Completed Children’s Oncology Group 2002-06-30
NCT00002475 Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00002475 Completed National Cancer Institute (NCI) 2007-12-31
NCT00002473 Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer https://ClinicalTrials.gov/show/NCT00002473 Completed European Organisation for Research and Treatment of Cancer - EORTC 2011-02-28
NCT00001570 A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer https://ClinicalTrials.gov/show/NCT00001570 Completed National Institutes of Health Clinical Center (CC) NA
NCT00035243 EPO906 Therapy in Patients With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT00035243 Completed Novartis 2003-08-31
NCT00034281 Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 https://ClinicalTrials.gov/show/NCT00034281 Completed Takeda 2003-09-30
NCT00328861 Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer https://ClinicalTrials.gov/show/NCT00328861 Completed National Institutes of Health Clinical Center (CC) 2007-07-31
NCT00012337 ZD 1839 in Treating Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00012337 Completed National Cancer Institute (NCI) NA
NCT00003126 Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer https://ClinicalTrials.gov/show/NCT00003126 Completed Loyola University 2002-08-31
NCT00001302 A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 https://ClinicalTrials.gov/show/NCT00001302 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04107168 Microbiome Immunotherapy Toxicity and Response Evaluation https://ClinicalTrials.gov/show/NCT04107168 Recruiting Cambridge University Hospitals NHS Foundation Trust 2024-07-08
NCT03293563 UroCCR Database: French Research Network for Kidney Cancer https://ClinicalTrials.gov/show/NCT03293563 Recruiting University Hospital, Bordeaux 2021-12-31
NCT03292549 RObotic PArtial Nephrectomy National Study https://ClinicalTrials.gov/show/NCT03292549 Completed University Hospital, Bordeaux 2015-04-30
NCT03161613 Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico https://ClinicalTrials.gov/show/NCT03161613 Recruiting Bristol-Myers Squibb 2019-04-01
NCT03134027 Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers https://ClinicalTrials.gov/show/NCT03134027 Recruiting Duke University 2021-11-30
NCT03133286 Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) https://ClinicalTrials.gov/show/NCT03133286 Recruiting DxTerity Diagnostics 2019-09-06
NCT03097601 ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib https://ClinicalTrials.gov/show/NCT03097601 Active, not recruiting Centre Antoine Lacassagne 2019-12-30
NCT02821793 Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer https://ClinicalTrials.gov/show/NCT02821793 Recruiting Institut Bergonié 2019-05-31
NCT02627144 Bevacizumab in Metastatic Renal Cancer https://ClinicalTrials.gov/show/NCT02627144 Completed Hoffmann-La Roche 2014-09-30
NCT00033137 Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer https://ClinicalTrials.gov/show/NCT00033137 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00050752 Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer https://ClinicalTrials.gov/show/NCT00050752 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00026884 Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease https://ClinicalTrials.gov/show/NCT00026884 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001238 Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders https://ClinicalTrials.gov/show/NCT00001238 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03628859 BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer) https://ClinicalTrials.gov/show/NCT03628859 Recruiting Centre Leon Berard 2023-06-30
NCT02499458 Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer https://ClinicalTrials.gov/show/NCT02499458 Completed Lawson Health Research Institute 2018-12-31
NCT02457715 Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis https://ClinicalTrials.gov/show/NCT02457715 Completed Duke University 2017-10-31
NCT02450448 The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02450448 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02404584 The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer https://ClinicalTrials.gov/show/NCT02404584 Completed Centre Hospitalier Universitaire de Nīmes 2019-05-21
NCT02371551 Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT https://ClinicalTrials.gov/show/NCT02371551 Completed University Hospital Inselspital, Berne 2017-10-20
NCT02228954 IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) https://ClinicalTrials.gov/show/NCT02228954 Active, not recruiting Radboud University 2018-03-05
NCT02204800 Active Surveillance of the Small Renal Mass https://ClinicalTrials.gov/show/NCT02204800 Recruiting Yale University 2021-08-31
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. https://ClinicalTrials.gov/show/NCT02186925 Recruiting Meir Medical Center 2019-08-31
NCT02156310 Mechanisms of Anti-VEGF Induced Hypertension https://ClinicalTrials.gov/show/NCT02156310 Completed Flinders University 2012-12-31
NCT02143492 Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC https://ClinicalTrials.gov/show/NCT02143492 Completed Argos Therapeutics 2015-07-31
NCT02121730 Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions https://ClinicalTrials.gov/show/NCT02121730 Recruiting Centre Hospitalier Universitaire, Amiens 2019-08-31
NCT02087852 Kidney Cancer DNA Registry https://ClinicalTrials.gov/show/NCT02087852 Recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT02086734 Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02086734 Completed Ludwig-Maximilians - University of Munich 2018-07-31
NCT01314391 Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01314391 Completed Children’s Oncology Group 2016-05-31
NCT01971905 Perfusion Scanning’s for Kidney Tumors https://ClinicalTrials.gov/show/NCT01971905 Completed Zealand University Hospital 2018-01-31
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01808079 Gene Analysis in Studying Susceptibility to Wilms Tumor https://ClinicalTrials.gov/show/NCT01808079 Completed Children’s Oncology Group 2009-11-30
NCT01576211 Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01576211 Completed Children’s Oncology Group 2016-05-31
NCT01576198 Studying Biomarkers in Samples From Younger Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01576198 Completed Children’s Oncology Group 2016-07-31
NCT01553175 Studying Gene Expression in Samples From Patients With Rhabdoid Tumors https://ClinicalTrials.gov/show/NCT01553175 Completed Children’s Oncology Group 2016-07-31
NCT01550393 Biomarkers in Urine Samples From Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01550393 Completed Children’s Oncology Group 2016-07-31
NCT01544569 Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors https://ClinicalTrials.gov/show/NCT01544569 Completed Children’s Oncology Group 2016-05-31
NCT01542333 Studying Biomarkers in Samples From Younger Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01542333 Completed Children’s Oncology Group 2016-05-31
NCT01493817 Biomarkers in Samples From Younger Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01493817 Completed Children’s Oncology Group 2016-05-31
NCT01465425 Extracolonic Findings on Computed Tomography (CT) Colonography https://ClinicalTrials.gov/show/NCT01465425 Enrolling by invitation American College of Radiology Imaging Network 2019-12-31
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) https://ClinicalTrials.gov/show/NCT01447199 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia https://ClinicalTrials.gov/show/NCT01444456 Completed Amgen 2013-08-31
NCT01339975 Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01339975 Completed University Hospital, Bordeaux 2014-05-31
NCT04415697 Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas https://ClinicalTrials.gov/show/NCT04415697 Completed Barretos Cancer Hospital 2020-02-20
NCT04392076 Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study https://ClinicalTrials.gov/show/NCT04392076 Recruiting University of Leeds 2020-12-31
NCT04377113 Cellular Immunity and Renal Cell Cancer https://ClinicalTrials.gov/show/NCT04377113 Recruiting Clinical Hospital Center Rijeka 2020-12-31
NCT04295174 KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other Biomarkers https://ClinicalTrials.gov/show/NCT04295174 Completed Odense University Hospital 2020-01-01
NCT04222374 Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC) https://ClinicalTrials.gov/show/NCT04222374 Recruiting University Hospital, Bordeaux 2020-04-30
NCT04213157 Laparoscopic Partial Nephrectomy for cT1 Tumors https://ClinicalTrials.gov/show/NCT04213157 Completed Samsun Liv Hospital 2019-08-30
NCT04154163 Appropriate Dosing to Optimise Personalised Cancer Treatments https://ClinicalTrials.gov/show/NCT04154163 Recruiting University of Dundee 2020-07-30
NCT04113486 Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations https://ClinicalTrials.gov/show/NCT04113486 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2021-09-30
NCT04072224 Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer’s Abacus: on the Kidney, Liver and Lung https://ClinicalTrials.gov/show/NCT04072224 Recruiting Centre Hospitalier Universitaire de NÄ«mes 2020-10-23
NCT03996850 SPECT/CT for the Characterization of Renal Masses https://ClinicalTrials.gov/show/NCT03996850 Recruiting Jonsson Comprehensive Cancer Center 2021-12-31
NCT03981497 Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms https://ClinicalTrials.gov/show/NCT03981497 Recruiting IRCCS San Raffaele 2024-02-28
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT03756597 PAN-study: Pan-Cancer Early Detection Study (PAN) https://ClinicalTrials.gov/show/NCT03756597 Recruiting Owlstone Ltd 2021-12-31
NCT03663946 A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread https://ClinicalTrials.gov/show/NCT03663946 Recruiting Bristol-Myers Squibb 2021-12-31
NCT03630692 Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs https://ClinicalTrials.gov/show/NCT03630692 Recruiting Institut Cancerologie de l’Ouest 2020-01-31
NCT03606044 3D Virtual Models as an Adjunct to Preoperative Surgical Planning https://ClinicalTrials.gov/show/NCT03606044 Completed Innersight Labs Ltd 2019-07-31
NCT03568435 Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants https://ClinicalTrials.gov/show/NCT03568435 Active, not recruiting Bristol-Myers Squibb 2020-12-31
NCT03455452 An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT03455452 Recruiting Bristol-Myers Squibb 2022-01-18
NCT03433534 Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer https://ClinicalTrials.gov/show/NCT03433534 Completed University Hospital, Tours 2018-12-21
NCT03414827 Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03414827 Recruiting Zealand University Hospital 2020-12-01
NCT01236053 Cancer in Patients With Gabapentin (GPRD) https://ClinicalTrials.gov/show/NCT01236053 Completed GlaxoSmithKline 2010-09-30
NCT01159717 CT Versus CEUS Findings of Complex Cystic Renal Lesions https://ClinicalTrials.gov/show/NCT01159717 Completed University Hospital, Basel, Switzerland 2008-12-31
NCT01138124 Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) https://ClinicalTrials.gov/show/NCT01138124 Completed GlaxoSmithKline 2010-08-31
NCT01118078 Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor https://ClinicalTrials.gov/show/NCT01118078 Completed Children’s Oncology Group 2016-05-31
NCT01117779 Tracking Renal Tumors After Cryoablation Evaluation https://ClinicalTrials.gov/show/NCT01117779 Active, not recruiting Galil Medical, a wholly owned indirect subsidiary of Boston Scientific 2021-09-30
NCT01109394 Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies https://ClinicalTrials.gov/show/NCT01109394 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01087060 Detection of Renal Malignancy of Complicated Renal Cysts https://ClinicalTrials.gov/show/NCT01087060 Completed Seoul National University Hospital 2008-03-31
NCT01050504 Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer https://ClinicalTrials.gov/show/NCT01050504 Recruiting University of Washington 2021-09-01
NCT01004783 Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors https://ClinicalTrials.gov/show/NCT01004783 Completed Children’s Oncology Group 2010-11-30
NCT00900536 DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE https://ClinicalTrials.gov/show/NCT00900536 Completed National Cancer Institute (NCI) NA
NCT00900276 Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants https://ClinicalTrials.gov/show/NCT00900276 Completed Wake Forest University Health Sciences 2011-04-30
NCT00900042 SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00900042 Completed Southwest Oncology Group 2002-12-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00897637 Gene Expression Profiles to Categorize Wilms Tumors https://ClinicalTrials.gov/show/NCT00897637 Completed Children’s Oncology Group 2016-05-31
NCT00873210 Study In Patients With Kidney Cancer Treated With Sutent https://ClinicalTrials.gov/show/NCT00873210 Completed Pfizer 2011-11-30
NCT04146064 Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response https://ClinicalTrials.gov/show/NCT04146064 Recruiting University Health Network, Toronto 2024-05-31
NCT00806650 Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer https://ClinicalTrials.gov/show/NCT00806650 Completed City of Hope Medical Center 2017-11-15
NCT01614808 Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor https://ClinicalTrials.gov/show/NCT01614808 Completed Children’s Oncology Group 2012-06-30
NCT04388917 Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Partial Nephrectomy? https://ClinicalTrials.gov/show/NCT04388917 Completed Centre Hospitalier Universitaire de Nice 2019-12-31
NCT00656955 Follow-Up Study of Kidney Cancer Patients https://ClinicalTrials.gov/show/NCT00656955 Completed National Institutes of Health Clinical Center (CC) 2013-05-31
NCT00617799 Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00617799 Completed University of Nebraska 2009-02-18
NCT00582621 Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders https://ClinicalTrials.gov/show/NCT00582621 Recruiting Memorial Sloan Kettering Cancer Center 2021-12-31
NCT00507884 Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors https://ClinicalTrials.gov/show/NCT00507884 Active, not recruiting M.D. Anderson Cancer Center 2022-09-01
NCT00340457 Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States https://ClinicalTrials.gov/show/NCT00340457 Completed National Institutes of Health Clinical Center (CC) NA
NCT00263107 Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. https://ClinicalTrials.gov/show/NCT00263107 Completed University of California, Davis NA
NCT00088803 DNA Variations in the Gene in Young Patients With Wilms’ Tumor https://ClinicalTrials.gov/show/NCT00088803 Completed Children’s Oncology Group 2016-05-31
NCT00075348 Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome https://ClinicalTrials.gov/show/NCT00075348 Completed National Institutes of Health Clinical Center (CC) 2008-12-31
NCT00001668 Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors https://ClinicalTrials.gov/show/NCT00001668 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03301493 Genomic Testing and Resulting Medical Decisions https://ClinicalTrials.gov/show/NCT03301493 Recruiting Arbeitsgemeinschaft medikamentoese Tumortherapie 2019-12-31
NCT03160274 Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions https://ClinicalTrials.gov/show/NCT03160274 Recruiting The University of Texas Health Science Center at San Antonio 2030-12-31
NCT02346435 The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry https://ClinicalTrials.gov/show/NCT02346435 Recruiting Johns Hopkins University 2024-01-31
NCT02333279 Cancer Development In Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT02333279 Completed University of Zurich 2018-05-31
NCT01888198 Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment https://ClinicalTrials.gov/show/NCT01888198 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-06-30
NCT03857373 Renal Cancer Detection Using Convolutional Neural Networks https://ClinicalTrials.gov/show/NCT03857373 Recruiting Zealand University Hospital 2023-01-01
NCT03616951 Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT https://ClinicalTrials.gov/show/NCT03616951 Recruiting University of Aarhus 2023-01-01
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31